Robert W. Hicklin

机构：Pfizer (United States), Proteostasis Therapeutics (United States)

发表论文 27 篇 · 总被引 2058 次 · h-index 11

代表论文

• A robotic platform for flow synthesis of organic compounds informed by AI planning (2019 · Science · 被引 1124)
• A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products (2013 · Nature Chemistry · 被引 319)
• Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis (2019 · Nature Chemistry · 被引 231)
• Synthesis of Complex and Diverse Compounds through Ring Distortion of Abietic Acid (2013 · Angewandte Chemie International Edition · 被引 127)
• Minimizing E-factor in the continuous-flow synthesis of diazepam and atropine (2017 · Bioorganic & Medicinal Chemistry · 被引 70)
• Automated Nanomole-Scale Reaction Screening toward Benzoate Bioisosteres: A Photocatalyzed Approach to Highly Elaborated Bicyclo[1.1.1]Pentanes (2021 · ACS Catalysis · 被引 49)